BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Stock Technical Analysis
NASDAQ:BBOT - KYG4444H1011 - Common Stock
Taking everything into account, BBOT scores 2 out of 10 in our technical rating. BBOT's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
The technical rating of BBOT is bad and it also does not present a quality setup at the moment. Prices have been extended to the downside lately. For a nice entry it is better to wait for a consolidation.
More info and screens
9.21
We found 1 important resistance area.
- A resistance zone ranging from 9.57 to 9.71. This zone is formed by a combination of multiple trend lines in multiple time frames.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | NEUTRAL | NEUTRAL | The long term trend for BBOT is neutral. |
| ChartMill Short Term Trend Indicator | UP | POSITIVE | The short term trend for BBOT is up. |
| ChartMill Relative Strength | 0 | NEGATIVE | BBOT has a low relative strength, it was outperformed by 100% off all stocks on the market. |
| Relative Strength Index/RSI (14) | 46.86 | NEUTRAL | The RSI value for BBOT is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0.53 | POSITIVE | The MACD value suggests BBOT has a positive trend, although the MACD value is declining. |
| Average Directional Index/ADX (14) | 13.4 | NEGATIVE | The low ADX value for BBOT suggests a weak or negative trend. |
NASDAQ:BBOT (8/27/2025, 4:10:09 PM)
9.3
-0.29 (-2.97%)